[HTML][HTML] Chimeric antigen receptor T-cell immunotherapy in breast cancer: development and challenges
S Toulouie, G Johanning, Y Shi - Journal of Cancer, 2021 - ncbi.nlm.nih.gov
Chimeric antigen receptor (CAR) T-cell therapy is an innovative form of immunotherapy
wherein autologous T-cells are genetically modified to express chimeric receptors encoding …
wherein autologous T-cells are genetically modified to express chimeric receptors encoding …
The impact of tumor-associated macrophages found at mammary carcinoma sites is dependent upon the tumor type
M Chang, K Ellmaker, A Esposito… - Immunological …, 2023 - Taylor & Francis
Background Previously, we reported that tumor-associated macrophages (TAM) at early
sites of mammary carcinoma showed a decrease in ATP production rate and a higher …
sites of mammary carcinoma showed a decrease in ATP production rate and a higher …